Total Payments
$453,035
2024 Payments
$45,939
Companies
8
Transactions
538
Payment Breakdown by Category
Consulting$247,161 (54.6%)
Research$121,898 (26.9%)
Travel$40,623 (9.0%)
Other$32,102 (7.1%)
Food & Beverage$8,882 (2.0%)
Education$2,368 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $247,161 | 58 | 54.6% |
| Unspecified | $121,898 | 52 | 26.9% |
| Travel and Lodging | $40,623 | 66 | 9.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,102 | 42 | 5.3% |
| Food and Beverage | $8,882 | 222 | 2.0% |
| Honoraria | $8,000 | 1 | 1.8% |
| Education | $2,368 | 97 | 0.5% |
Payments by Type
General
$331,136
486 transactions
Research
$121,898
52 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $185,207 | 259 | $0 (2024) |
| Allergan, Inc. | $129,837 | 174 | $0 (2023) |
| MERZ NORTH AMERICA, INC. | $112,593 | 61 | $0 (2024) |
| Galderma Laboratories, L.P. | $20,525 | 19 | $0 (2024) |
| Merz Pharmaceuticals GmbH | $4,697 | 19 | $0 (2017) |
| REVANCE THERAPEUTICS, INC. | $100.51 | 4 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $45.76 | 1 | $0 (2019) |
| Boston Scientific Corporation | $30.86 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,939 | 64 | ABBVIE INC. ($37,926) |
| 2023 | $183,218 | 163 | ABBVIE INC. ($112,105) |
| 2022 | $54,791 | 90 | AbbVie Inc. ($34,626) |
| 2021 | $29,495 | 49 | Allergan, Inc. ($28,946) |
| 2020 | $21,079 | 52 | Allergan, Inc. ($17,464) |
| 2019 | $42,054 | 55 | Allergan Inc. ($34,540) |
| 2018 | $48,707 | 18 | Allergan Inc. ($33,939) |
| 2017 | $27,751 | 47 | MERZ NORTH AMERICA, INC. ($16,491) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $413.15 | General |
| 12/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 11/27/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,450.00 | General |
| 11/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $55.36 | General |
| 11/15/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| 11/15/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $35.51 | General |
| 11/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $9.03 | General |
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $335.95 | General |
| 11/02/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $1,026.96 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $62.50 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $48.08 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.32 | General |
| 11/01/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $202.31 | General |
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $203.40 | General |
| 09/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.34 | General |
| 09/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.57 | General |
| 09/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $6.84 | General |
| 08/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $67.11 | General |
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $155.70 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Prospective, Multicenter, Controlled, Evaluator-blind, Randomized Study to Investigate the Effectiveness and Safety of Diluted RADIESSE for Treatment of Decollete Wrinkles | Merz North America, Inc. | $69,109 | 4 |
| A Single-Center, Split-Face, Randomized, Investigator-Blind Pilot Study to Compare the Efficacy and Tolerability of Two Post-Procedure Skin Care Regimens on Subjects with a Pre-Elected Intense Pulse Light IPL Laser Treatment | Allergan Inc. | $33,825 | 2 |
| Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: 2-Year Results from a Pivotal Single-Blind Randomized Controlled Study | AbbVie Inc. | $4,500 | 1 |
| A SINGLE CENTER, DOUBLE BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ONABOTULINUMTOXINA TO THE DEPRESSOR ANGULI ORIS | Allergan, Inc. | $3,681 | 1 |
| Safety and Effectiveness of Juvederm VOLUMA XC Injectable Gel for Cheek Augmentation | ABBVIE INC. | $3,600 | 1 |
| Mid-Face Volume Deficit Scale Revalidation Study | AbbVie Inc. | $3,262 | 17 |
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,939 | 5 |
| EVALUATION OF EFFECTIVENESS AND SAFETY OF RADIESSE (+) FOR THE IMPROVEMENT OF JAWLINE VOLUME AND CONTOUR | MERZ NORTH AMERICA, INC. | $1,084 | 7 |
| Medical Aesthetics: Reliability of the Investigator and Participant-Assessed Masseter Muscle Prominence Scale | ABBVIE INC. | $500.39 | 7 |
| MMP Scale Validation Study | ABBVIE INC. | $383.27 | 6 |
| A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence | ABBVIE INC. | $14.82 | 1 |
About Dr. Amir Moradi, MD
Dr. Amir Moradi, MD is a Otolaryngology healthcare provider based in Vista, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467567032.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Moradi, MD has received a total of $453,035 in payments from pharmaceutical and medical device companies, with $45,939 received in 2024. These payments were reported across 538 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($247,161).
Ad
Practice Information
- Specialty Otolaryngology
- Location Vista, CA
- Active Since 08/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1467567032
Products in Payments
- BOTOX (Biological) $39,212
- XEOMIN (Biological) $12,881
- ALLODERM (Device) $10,307
- Xeomin (Biological) $5,043
- BOTOX COSMETIC (Biological) $2,023
- STRATTICE (Device) $800.00
- DAXXIFY (Drug) $100.51
- RESONATE (Device) $30.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.